Department

Pharmacy Practice

Home Academics Departments Faculty Michael P. Kane, PHARM.D., FCCP, BCPS, BCACP

Professor
Focus: Endocrinology

Contact Information
(518) 694-7239
michael.kane@0933282516.com


Speaker Request
Michael P. Kane, PHARM.D., FCCP, BCPS, BCACP

EDUCATION

  • Pharm.D., Medical University of South Carolina 
  • Clinical Pharmacy Resident, Adult Internal Medicine, 南卡罗来纳医科大学附属医院, Charleston, SC
  • 医院药房住院医师，格林威治医院协会，康涅狄格州格林威治 
  • B.S., Albany College of Pharmacy and Health Sciences

COURSES TAUGHT AT ACPHS

  • 综合解决问题工作坊6(主持人)
  • PTPM Endocrinology
  • 门诊护理内分泌/内科轮转

RESEARCH INTERESTS

  • 评估新药治疗糖尿病和骨质疏松症的安全性和有效性.

HONORS AND APPOINTMENTS

  • 2003年6月当选为美国临床药学学院院士
  • 2003年美国临床药学学院纽约州分会颁发的年度研究员奖获得者, May 21, 2004, Syracuse, NY
  • Clinical practice site identified as the “Favorite Rotation” of ACP clerkship students for 2004; presented March 2005.
  • 当选2005年首都区37岁及以上男子高级棒球联盟最有价值球员
  • 客座教授奖:药学客座专家, Endocrinology; Health Manpower Development Plan, Singapore Ministry of Health, Feb 16-27, 2009, Singapore
  • 2010年美国临床药学学院的获得者, Clinical Practice Award; presented October 14, 2010, Austin, TX
  • 2015年被任命为东北肾脏基金会董事会成员.
  • 《全球十大赌博靠谱的平台》于2018年入选侯爵世界名人录(由世界前3%的专业人士组成).
  • 入选2019-2020年度奥尔巴尼药学与健康科学学院辅导员, October, 2020.
  • 当选为首都地区男子高级棒球联盟名人堂- 2020年.

CLINICAL AFFILIATIONS

  • 临床药学专家-奥尔巴尼医疗中心社区内分泌科(原内分泌组), Albany, NY
  • 成人内科/内分泌学实习导师
  • Fellow of the American College of Clinical Pharmacy
  • Board Certified in Pharmacotherapy (since 1991)
  • 流动护理药剂委员会认证(自2011年起)

SCHOLARLY ACTIVITY

PUBLICATIONS
  • Arceri V, Kane MP. Hyperthyroidism. 在药物治疗原则和实践研究指南:基于病例的护理计划方法, 第6版(Chisholm-Burns等人的第6版的配套教科书). Pharmacotherapy Principles and Practice); Sept 2022. 
  • Kane MP, Bakst G. Thyroid Disorders. 在DiPiro JT, Yee GC, Posey L, Haines ST, Nolin TD, Ellingrod V. eds. Pharmacotherapy: A Pathophysiologic Approach, 12e New York, NY: McGraw-Hill; 2022; Chapter 96: Thyroid Disorders; 1-50. 
  • Cibotaru D, Celestin MN, Kane MP, Musteata M. Comparison of Liquid-Liquid Extraction, Microextraction, 超滤法测定睾酮和苯妥英游离浓度. Bioanalysis. 2022;14(4): 195-204.
  • Quinn HB, Busch RS, Kane MP. 门诊内分泌科低磷血症的发生与负担. Endocrine Practice, 2021;27:1189-1192. 
  • Cibotaru D, Celestin MN, Kane MP, Musteata M. 同时测定游离浓度的方法, Total Concentration, and Plasma Binding Capacity in Clinical Samples. J Pharm Sci 2021;110:1401-11.doi: 10.1016/j.xphs.2020.12.001.
  • Kane MP, Triplitt C, Solis-Herrera C. 口服西马鲁肽治疗2型糖尿病:药师实用指南. Am J Health Syst Pharm . 2021 Mar 18;78(7):556-567. doi: 10.1093/ajhp/zxaa413.
  • Kane MP, Bakst G. Thyroid disorders. In: DiPiro JT, Yee GC, Posey LM, Haines ST, Nolin TD, Ellingrod V，等. Pharmacotherapy: A Pathophysiologic Approach, 11ed. New York, NY: McGraw-Hill Education, 2019.
  • Kane MP, Triplitt C, Solis-Herrera C. 口服西马鲁肽治疗2型糖尿病:药师实用指南. 接受发表，美国卫生系统药学杂志.
  • Kuchis MM, Eldeiry A, Busch RS, Racz MJ, Kane MP. 蛋白转化酶Subtilisin/Kexin Type 9 (PCSK9)抑制剂的长期安全性和有效性. Endocr Pract (Abstract). 2020;26(suppl 2):166-167.
  • 治疗学ACCP/ASHP门诊护理药学预备审查和再认证课程的更新, 2020 ed. 张志强，张志强，张志强，等。美国临床药学杂志，2008:47-108.
  • Kuchis M, Kane MP. 亚临床甲状腺功能减退:不要让数字欺骗你:左甲状腺素不是万灵药. March 3, 2020 http://iforumrx.org/commentary/don%E2%80%99t-let-numbers-fool-you-levo..。
  • McGreevy JL, Kane MP, Busch RS, Bakst G, ElDeiry SS. 药剂师经营的合成代谢骨质疏松症诊所:阿巴巴拉肽描述性报告. J Am Pharm Assoc. 2019;59(4):593-597. 
  • Kane MP, Bakst G. Thyroid disorders. In: DiPiro JT, Yee GC, Posey LM, Haines ST, Nolin TD, Ellingrod V，等. Pharmacotherapy: A Pathophysiologic Approach, 11ed. New York, NY: McGraw-Hill Education, 2019.
  • Farina K, Kane MP. 程序性细胞死亡-1单克隆抗体治疗与1型糖尿病:文献综述. J Pharm Pract. 2019 Jul 3:897190019850929. doi: 10.1177/0897190019850929 
  • Endocrine Disorders. In: Bainbridge JL, Cardone K, Cross LB, et al. 治疗学ACCP/ASHP门诊护理药学预备审查和再认证课程的更新, 2019 ed. 张志强，张志强。美国临床药学杂志，2019:631-93.
SELECTED POSTER/PLATFORM PRESENTATIONS
  • Arceri V, Kane MP, Quinn HB, Telese M, Racz M, Busch RS. 阿巴巴拉肽的实施和随访:药剂师经营的合成代谢骨质疏松症诊所的实际结果. 海报于2022年6月11日在佐治亚州亚特兰大举行的2022内分泌学会年会上公布. 
  • Updates in Diabetes Management: The Elderly. 在纽约美国咨询药剂师协会中州分会会议上发表, Syracuse, NY, June 1, 2022. 
  • 骨质疏松症不断发展的治疗范式:药剂师在优化护理中的整体作用. Pharmacy Times CE, Cranbury, NJ, April 27, 2022. 
  • Quinn HB, Busch RS, Kane MP. 摘要编号:8734内分泌学会年会. 摘要题目:门诊内分泌科低磷酸症的患病率和负担. Poster session: P08. Parathyroid and Rare Bone Disorders. Took place online, ENDO 2021, March 20-23, 2021. 
  • PSSNY/CPESN糖尿病自我护理管理(DSMES)训练营. 糖尿病最新进展:药物、临床指南和治疗建议. Presented Nov 8, 2020, virtual presentation.
  • Kuchis MM, Eldeiry A, Busch RS, Racz M, Kane MP. 蛋白转化酶枯草素/kexin 9型(PCSK9)抑制剂的长期安全性和有效性. EMBRAACE 2020: The AACE 29th Annual Scientific & Clinical Congress; Washington, DC May 10, 2020. (On-line presentation due to COVID-19 pandemic).
  • ACCP/ASHP 2020 Ambulatory Care Pharmacy Preparatory Review and Recertification Course; Endocrine Disorders. Presented March 5, 2020, Henderson, NV.
  • Current Issues in Hypothyroidism. 护士执业协会纽约州第35届年会. Presented October 19, 2019, Verona, NY.
  • ACCP/ASHP 2019 Ambulatory Care Pharmacy Preparatory Review and Recertification Course; Endocrine Disorders. Presented May 3, 2019, Minneapolis, MN.
  • McGreevy JL, Cherian S, Kane MP, Busch RS, Racz M. A real-world GLP-1 receptor agonist switch study. 在2019年治疗学ACCP/ASHP更新会议上发表. Louis College of Pharmacy, St. Louis, Missouri, April 28, 2019.
RESEARCH GRANTS

阿巴巴拉肽的实施和随访:药剂师经营的合成代谢骨质疏松症诊所的实际结果. Kane MP, Arceri V, Quinn H, Busch RS. Radius Pharmaceuticals, $42,640; Dec 2021.

在门诊护理内分泌实践中低磷血症的患病率和负担. Kane MP, Quinn H, Busch RS. Awarded $42,640; Alexion Pharmaceuticals; July 2020.

同时测定游离、总和标准化浓度的生物活性化合物. Musteata FM, Kane MP. National Institutes of Health. Grant Number: 1R15GM126510-01  FAIN: R15GM126510. Awarded $480,000. 09/01/2018 – 08/31/2021.

 


ALBANY CAMPUS
REQUEST INFO
APPLY NOW